Name | AMG176 |
---|
Description | AMG-176 is a potent, selective and orally bioavailable MCL-1 inhibitor, with a Ki of 0.13 nM. |
---|---|
Related Catalog | |
Target |
Mcl-1:0.13 nM (Ki) |
In Vitro | AMG-176 is an inhibitor of induced myeloid leukemia cell differentiation protein MCL-1 (Ki=0.13 nM), with potential pro-apoptotic and antineoplastic activities. Upon administration, AMG 176 binds to and inhibits the activity of MCL-1. This disrupts the formation of MCL-1/Bcl-2-like protein 11 (BCL2L11; BIM) complexes and induces apoptosis in tumor cells[1][2]. |
References |
Molecular Formula | C33H41ClN2O5S |
---|---|
Molecular Weight | 613.21 |
Storage condition | 2-8℃ |